UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescentsResearch in context
Alexandra Liebmann,
Jakob Admard,
Sorin Armeanu-Ebinger,
Hannah Wild,
Michael Abele,
Axel Gschwind,
Olga Seibel-Kelemen,
Christian Seitz,
Irina Bonzheim,
Olaf Riess,
German Demidov,
Marc Sturm,
Malou Schadeck,
Michaela Pogoda,
Ewa Bien,
Malgorzata Krawczyk,
Eva Jüttner,
Thomas Mentzel,
Maja Cesen,
Elke Pfaff,
Michal Kunc,
Stephan Forchhammer,
Andrea Forschner,
Ulrike Leiter-Stöppke,
Thomas K. Eigentler,
Dominik T. Schneider,
Christopher Schroeder,
Stephan Ossowski,
Ines B. Brecht
Affiliations
Alexandra Liebmann
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Jakob Admard
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Sorin Armeanu-Ebinger
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Hannah Wild
Paediatric Hematology and Oncology, University Children’s Hospital Tübingen, Tübingen, Germany
Michael Abele
Paediatric Hematology and Oncology, University Children’s Hospital Tübingen, Tübingen, Germany
Axel Gschwind
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Olga Seibel-Kelemen
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Christian Seitz
Paediatric Hematology and Oncology, University Children’s Hospital Tübingen, Tübingen, Germany
Irina Bonzheim
Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany
Olaf Riess
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
German Demidov
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Marc Sturm
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Malou Schadeck
SYNLAB MVZ Human Genetics Freiburg GmbH, Freiburg, Germany
Michaela Pogoda
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany; NGS Competence Center Tübingen, Tübingen, Germany
Ewa Bien
Department of Paediatrics, Hematology, Oncology, Medical University of Gdansk, Poland
Malgorzata Krawczyk
Department of Paediatrics, Hematology, Oncology, Medical University of Gdansk, Poland
Eva Jüttner
Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany
Summary: Background: Genomic characterisation has led to an improved understanding of adult melanoma. However, the aetiology of melanoma in children is still unclear and identifying the correct diagnosis and therapeutic strategies remains challenging. Methods: Exome sequencing of matched tumour-normal pairs from 26 paediatric patients was performed to study the mutational spectrum of melanomas. The cohort was grouped into different categories: spitzoid melanoma (SM), conventional melanoma (CM), and other melanomas (OT). Findings: In all patients with CM (n = 10) germline variants associated with melanoma were found in low to moderate melanoma risk genes: in 8 patients MC1R variants, in 2 patients variants in MITF, PTEN and BRCA2. Somatic BRAF mutations were detected in 60% of CMs, homozygous deletions of CDKN2A in 20%, TERTp mutations in 30%. In the SM group (n = 12), 5 patients carried at least one MC1R variant; somatic BRAF mutations were detected in 8.3%, fusions in 25% of the cases. No SM showed a homozygous CDKN2A deletion nor a TERTp mutation. In 81.8% of the CM/SM cases the UV damage signatures SBS7 and/or DBS1 were detected. The patient with melanoma arising in giant congenital nevus (CNM) demonstrated the characteristic NRAS Q61K mutation. Interpretation: UV-radiation and MC1R germline variants are risk factors in the development of conventional and spitzoid paediatric melanomas. Paediatric CMs share genomic similarities with adult CMs while the SMs differ genetically from the CM group. Consistent genetic characterization of all paediatric melanomas will potentially lead to better subtype differentiation, treatment, and prevention in the future. Funding: Found in Acknowledgement.